Addressing the Limitations of VR for Crohn’s Pain Relief

Virtual reality (VR) shows increasing promise as an adjunct therapy for reducing Crohn’s disease pain. However, the technology still has limitations when used for abdominal pain relief.

Understanding the gaps in research and current VR capabilities helps set realistic expectations.

Here are some weaknesses to consider:

Limited Clinical Research

While initial studies are positive, large-scale randomized clinical trials on VR for Crohn’s pain are still sparse. Much of the research has focused on acute pain rather than chronic abdominal discomfort. More evidence is needed on optimal protocols.

Short Treatment Effects

The pain relief from VR sessions tends to be temporary in some cases, with symptoms returning in full force shortly after a session ends. More research on sustaining VR's benefits long-term and preventing adaptation is needed.

Anecdotally many people have exp[erienced a "flywheel" effect, meaning the effectiveness of pain distraction continues way after the immersion into VR.

Lack of Customisation

Most VR pain apps are designed for general chronic pain, not Crohn’s specifically. They don’t account for triggers like intestinal stimuli and lack customization for fatigue, nausea, etc. Specialized Crohn’s VR is scarce and only available via clinicians etc.

Difficulty During Severe Flares

During peak Crohn's flares with severe diarrhea, nausea, and fatigue, it can be difficult to tolerate VR headsets and focus on virtual content. Flexible options for different flare severity are lacking, so expanding ways to deliver near immersion is key, especially via devices we use daily, Phone, Tablet and Smart TV etc.

Unreliable Analgesia

VR helps reduce pain perception but doesn't act as a true analgesic to treat pain's underlying cause. It may fall short for excruciating flares and isn't intended as a replacement for medications when needed.

Isolation Side Effects

Overuse of VR for social isolation and escapism from illness can backfire. VR should complement real-world connections and therapy. Moderation is important.

Affordability Barriers

Most clinical VR therapy remains expensive and inaccessible to many patients. While options are improving, cost continues to be a barrier to regular use for lower-income patients, makinmg it near impossible to get respite from pain in many people.

Motion Sickness

A significant portion of users experience dizziness, nausea, and headaches from VR. This is especially problematic for those already suffering Crohn's stomach symptoms. Motion sickness reduction remains a challenge. But with better VR headsets, this seems to be a rapidly diminishing issue.

While the technology holds promise, Crohn’s patients considering VR pain management should understand there are still many limitations and unknowns.

However, rapidly advancing consumer VR could help address certain weaknesses like cost and customization in the future.

In the meantime, reasonable expectations are important.